Trials / Unknown
UnknownNCT05121922
Sense of Coherence and Empowerment at Patients With MUPS
Sense of Coherence and Empowerment at Patients With Medically Unexplained Physical Symptoms in General Practice
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Oslo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a study on Metacognitive therapy in general practice in Norway. The intervention is a small pilot study to examine whether Metacognitive therapy is feasible in an ordinary general practice. Will the physicians be capable to learn and provide the therapy method for their patients with MUPS and is is possible to implement this in an ordinary general practice routine? Both physicians and their patients will be asked to respond to a questionnaire on perceived utility of the treatment.
Detailed description
Metacognitive therapy is different from Cognitive therapy in the sense that it adresses the individual's attention towards potential worries and threats and also the management performed by the patient to avoid these. Also the individual's capacity to produce empowerment to manage these threats are of interest in the talks with the health care provider. - In this study, General Practitioners with specific training in Metacognitive therapy will be asked to recruit 2-3 patients with Medically Unexplained Physical Symptoms each and invite them to a series of Metacognitive Therapy. The patients and physicians will then provide their assessments of the treatment on a number of questionnaires. To explore the Sense of coherence and Empowerment among patients with Medically Unexplained Symptoms, the physicians will be asked to recruit six patients each to respond to a questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Metacognitive Therapy | Psychological treatment provided by the patient's regular general practitioner |
Timeline
- Start date
- 2021-08-15
- Primary completion
- 2023-06-30
- Completion
- 2025-06-30
- First posted
- 2021-11-16
- Last updated
- 2022-11-09
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT05121922. Inclusion in this directory is not an endorsement.